While the high sensitivity of RDTs that detect HRP2 is an advantage, persistent HRP2 antigenaemia for several weeks after antimalarial treatment in high malaria transmission settings compromises the specificity of these RDTs for detecting clinical malaria [5]. Here, HDGFL2 is linked to malaria.